Hemostatic laboratory derangements in COVID-19 with a focus on platelet count

References

• WHO COVID-19 Dashboard. [cited 2020 Apr 30]. Available from: https://covid19.who.int/
   Google Scholar
• Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID‐19. J Thromb Haemost 2020;0–1. doi:10.1111/jth.14849
   Web of Science ®Google Scholar
• Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G, Dimopoulos MA, et al. Hematological findings and complications of COVID-19. Am J Hematol 2020. doi:10.1002/ajh.25829
   Web of Science ®Google Scholar
• Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020;18(5):1094–1099. doi:10.1111/jth.14817
   PubMed Web of Science ®Google Scholar
• Deng Y, Liu W, Liu K, Fang -Y-Y, Shang J, zhou L, Wang K, Leng F, Wei S, Chen L, et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study. Chin Med J (Engl) 2020 Mar. doi:10.1097/CM9.0000000000000824
   Web of Science ®Google Scholar
• Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020;18:844–847. doi:10.1111/jth.14768
   PubMed Web of Science ®Google Scholar
• Klok FA, Kruip, MJ, Van der Meer, NJ, Arbous, MS, Gommers, DA, Kant, KM, Kaptein, FH, van Paassen, J, Stals, MA, Huisman, MV, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res 2020 Apr. doi:10.1016/j.thromres.2020.04.041
   Web of Science ®Google Scholar
• Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, Kucher N, Studt J-D, Sacco C, Alexia B, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 2020;191:9–14. doi:10.1016/j.thromres.2020.04.024
   PubMed Web of Science ®Google Scholar
• Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian CD, Ageno W, Madjid M, Guo Y, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol 2020 Apr. doi:10.1016/j.jacc.2020.04.031
   Web of Science ®Google Scholar
• Lippi G, Favaloro EJ. D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thromb Haemost 2020 Apr. doi:10.1055/s-0040-1709650
   Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Guan W, Ni Z, Hu Y, Liang W-H, Ou C-Q, He J-X, Liu L, Shan H, Lei C-L, Hui DSC, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA J Am Med Assoc 2020;323(11):1061–1069. doi:10.1001/jama.2020.1585
   PubMed Web of Science ®Google Scholar
• Favaloro EJ, Lippi G. Recommendations for minimal laboratory testing panels in patients with COVID-19: potential for prognostic monitoring. Semin Thromb Hemost 2020;46(3):379–382. doi:10.1055/s-0040-1709498
   PubMed Web of Science ®Google Scholar
• Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med 2020. doi:10.1515/cclm-2020-0198
   Web of Science ®Google Scholar
• Han H, Yang L, Liu R, Liu F, Wu K-L, Li J, Liu X-H, Zhu C-L, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med 2020 Mar. doi:10.1515/cclm-2020-0188
   Web of Science ®Google Scholar
• Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, Mucheli SS, Kuperan P, Ong KH, et al. Hematologic parameters in patients with COVID‐19 infection. Am J Hematol 2020 Mar;ajh.25774. doi:10.1002/ajh.25774
   Web of Science ®Google Scholar
• Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY, Loh J, Ng O-T, Marimuthu K, Ang LW, Mak TM, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA J Am Med Assoc 2020 Apr;323:1488. doi:10.1001/jama.2020.3204
   PubMed Web of Science ®Google Scholar
• Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020. doi:10.1001/jamainternmed.2020.0994
   Web of Science ®Google Scholar
• Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8:475–481. doi:10.1016/S2213-2600(20)30079-5
   PubMed Web of Science ®Google Scholar
• Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, Lee M, et al. Characteristics and outcomes of 21 critically Ill patients with COVID-19 in Washington State. JAMA J Am Med Assoc 2020;323:1612. doi:10.1001/jama.2020.4326
   PubMed Web of Science ®Google Scholar
• Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, Greninger AL, Pipavath S, Wurfel MM, Evans L, et al. Covid-19 in critically Ill patients in the seattle region — case series. N Engl J Med 2020 Mar. doi:10.1056/nejmoa2004500
   PubMed Web of Science ®Google Scholar
• Qu R, Ling Y, Zhang YHZ, Wei L-Y, Chen X, Li X, Liu X-Y, Liu H-M, Guo Z, Ren H, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol 2020. doi:10.1002/jmv.25767
   PubMed Web of Science ®Google Scholar
• Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, Wang Z, Li J, Li J, Feng C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 2020;63(3):364–374. doi:10.1007/s11427-020-1643-8
   PubMed Web of Science ®Google Scholar
• Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, Pesenti A, Peyvandi F, Tripodi A, et al. Hypercoagulability of COVID‐19 patients in intensive care unit. A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost 2020 Apr;jth.14850. doi:10.1111/jth.14850
   PubMed Web of Science ®Google Scholar
• Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, Zhang Z, et al. D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19. J Thromb Haemost 2020 Apr;jth.14859. doi:10.1111/jth.14859
   Web of Science ®Google Scholar
• Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, Blair CN, Weber A, Barnes BJ, Egeblad M, et al. Neutrophil extracellular traps in COVID-19. JCI Insight 2020 Apr. doi:10.1172/jci.insight.138999
   PubMed Web of Science ®Google Scholar
• Spiezia L, Boscolo A, Poletto F, Cerruti, L, Tiberio, I, Campello, E, Navalesi, P, Simioni, P. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost 2020 Apr. doi:10.1055/s-0040-1710018
   PubMed Web of Science ®Google Scholar
• Bi X, SU Z, Yan H, Du J, Wang J, Chen L, Peng M, Chen S, Shen B, Li J, et al. Prediction of severe illness due to COVID-19 based on an analysis of initial fibrinogen to albumin ratio and platelet count. Platelets 2020 May;1–6. doi:10.1080/09537104.2020.1760230
   PubMed Web of Science ®Google Scholar
• Liu W, Tao Z-W, Wang L, Yuan M-L, Liu K, Zhou L, Wei S, Deng Y, Liu J, Liu H-G, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl) 2020;133(9):1032–1038. doi:10.1097/CM9.0000000000000775
   PubMed Web of Science ®Google Scholar
• Liu Y, Sun W, Guo Y, Chen, L, Zhang, L, Zhao, S, Long, D, Yu, L. Association between platelet parameters and mortality in coronavirus disease 2019: retrospective cohort study. Platelets. 2020. doi:10.1080/09537104.2020.1754383
   Web of Science ®Google Scholar
• Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020 Mar;1–3. doi:10.1007/s00134-020-05991-x
   Web of Science ®Google Scholar
• Yang X, Yang Q, Wang Y, Wu, Y, Xu, J, Yu, Y, Shang, Y. Thrombocytopenia and its association with mortality in patients with COVID‐19. J Thromb Haemost 2020 Apr. doi:10.1111/jth.14848
   Web of Science ®Google Scholar
• Lippi G, Plebani M, Michael Henry B. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta 2020 Mar. doi:10.1016/j.cca.2020.03.022
   Web of Science ®Google Scholar
• Escher R, Breakey N, Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res 2020;190:62. doi:10.1016/j.thromres.2020.04.014
   PubMed Web of Science ®Google Scholar
• Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395(10229):1033–1034. doi:10.1016/S0140-6736(20)30628-0
   PubMed Web of Science ®Google Scholar
• Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol 2020 Apr;1–4. doi:10.1007/s00277-020-04019-0
   PubMed Web of Science ®Google Scholar
• Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, Trilling M, Lu M, Dittmer U, Yang D, et al. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS‐CoV, MERS‐CoV, and 2019‐nCoV. J Med Virol 2020;92(5):491–494. doi:10.1002/jmv.25709
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, Chen H, Ding X, Zhao H, Zhang H, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 2020 Apr;382:e38. doi:10.1056/nejmc2007575
   PubMed Web of Science ®Google Scholar
• Bowles L, Platton S, Yartey N, Dave M, Lee K, Hart DP, MacDonald V, Green L, Sivapalaratnam S, Pasi KJ, et al. Lupus anticoagulant and abnormal coagulation tests in patients with Covid-19. N Engl J Med 2020 May;NEJMc2013656. doi:10.1056/NEJMc2013656
   Web of Science ®Google Scholar
• McDonald B, Davis RP, Kim SJ, Tse M, Esmon CT, Kolaczkowska E, Jenne CN, et al. Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice. Blood 2017;129(10):1357–1367. doi:10.1182/blood-2016-09-741298
   PubMed Web of Science ®Google Scholar
• Gould TJ, Vu TT, Swystun LL, Dwivedi DJ, Mai SHC, Weitz JI, Liaw PC, et al. Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms. Arterioscler Thromb Vasc Biol 2014;34(9):1977–1984. doi:10.1161/ATVBAHA.114.304114
   PubMed Web of Science ®Google Scholar
• Ma AC, Kubes P. Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis. J Thromb Haemost 2008;6(3):415–420. doi:10.1111/j.1538-7836.2007.02865.x
   PubMed Web of Science ®Google Scholar
• Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, Daßler-Plenker J, Guerci P, Huynh C, Knight JS, et al. Targeting potential drivers of COVID-19: neutrophil extracellular traps. J Exp Med 2020;217(6). doi:10.1084/jem.20200652
   PubMed Web of Science ®Google Scholar
• Fox SE, Akmatbekov A, Harbert JL, Li G, Brown JQ, Vander Heide RS. Pulmonary and cardiac pathology in Covid-19: the first autopsy series from New Orleans. medRxiv 2020 Apr;2020:04.06.20050575. doi:10.1101/2020.04.06.20050575
   Google Scholar
• Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev 2007;21(2):99–111. doi:10.1016/j.blre.2006.06.001
   PubMed Web of Science ®Google Scholar
• Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, Coppo P, Hejblum G, et al. Development and validation of the hscore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol 2014;66(9):2613–2620. doi:10.1002/art.38690
   PubMed Web of Science ®Google Scholar
• Chinese Clinical Trial Register (ChiCTR). The world health organization international clinical trials registered organization registered platform. [cited 2020 May 1]. Available from: http://www.chictr.org.cn/showprojen.aspx?proj=49409
   Google Scholar
• Yang M, Li CK, Li K, Hon KLE, Ng MHL, Chan PKS, Fok TF, et al. Hematological findings in SARS patients and possible mechanisms (review). Int J Mol Med 2004;14(2):311–315. doi:10.3892/ijmm.14.2.311
   PubMed Web of Science ®Google Scholar
• Thachil J. What do monitoring platelet counts in COVID‐19 teach us? J Thromb Haemost 2020 Apr;jth.14879. doi:10.1111/jth.14879
   Web of Science ®Google Scholar
• Amgalan A, Othman M. Exploring possible mechanisms for COVID-19 induced thrombocytopenia: unanswered questions. J Thromb Haemost 2020 Apr. doi:10.1111/jth.14832
   Web of Science ®Google Scholar
• Lefrançais E, Ortiz-Muñoz G, Caudrillier A, Mallavia B, Liu F, Sayah DM, Thornton EE, Headley MB, David T, Coughlin SR, et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature 2017;544(7648):105–109. doi:10.1038/nature21706
   PubMed Web of Science ®Google Scholar
• Yang M, Ng MHL, Chi KL. Thrombocytopenia in patients with severe acute respiratory syndrome (review). Hematology 2005;10(2):101–105. doi:10.1080/10245330400026170
   PubMed Web of Science ®Google Scholar
• Behrens K, Alexander WS. Cytokine control of megakaryopoiesis. Growth Factors 2018;36(3–4):89–103. doi:10.1080/08977194.2018.1498487
   PubMed Web of Science ®Google Scholar
• Kaser A, Brandacher G, Steurer W, Kaser S, Offner FA, Zoller H, Theurl I, Widder W, Molnar C, Ludwiczek O, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 2001;98(9):2720–2725. doi:10.1182/blood.V98.9.2720
   PubMed Web of Science ®Google Scholar
• Yamamoto K, De Waard V, Fearns C, Loskutoff DJ. Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo. Blood 1998;92(8):2791–2801. doi:10.1182/blood.v92.8.2791.420k24_2791_2801
   PubMed Web of Science ®Google Scholar
• Dunois-Lardé C, Capron C, Fichelson S, Bauer T, Cramer-Bordé E, Baruch D. Exposure of human megakaryocytes to high shear rates accelerates platelet production. Blood 2009;114(9):1875–1883. doi:10.1182/blood-2009-03-209205
   PubMed Web of Science ®Google Scholar
• Alexander WS, Roberts AW, Nicola NA, Li R, Metcalf D. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-Mpl. Blood 1996;87(6):2162–2170. doi:10.1182/blood.v87.6.2162.bloodjournal8762162
   PubMed Web of Science ®Google Scholar
• Akşit E, Kırılmaz B, Gazi E, Aydın F. Ticagrelor can be an important agent in the treatment of severe COVID-19 patients with myocardial infarction. Balkan Med J 2020 Apr. doi:10.4274/balkanmedj.galenos.2020.2020.4.100
   Web of Science ®Google Scholar
• Zhou X, Li Y, Yang Q. Antiplatelet therapy following percutaneous coronary intervention in patients complicated by COVID-19: implications from clinical features to pathological findings. Circulation 2020 Apr. doi:10.1161/circulationaha.120.046988
   Google Scholar
• Sexton TR, Zhang G, Macaulay TE, Callahan LA, Charnigo R, Vsevolozhskaya OA, Li Z, Smyth S, et al. Ticagrelor reduces thromboinflammatory markers in patients with pneumonia. JACC Basic to Transl Sci 2018;3(4):435–449. doi:10.1016/j.jacbts.2018.05.005
   PubMedGoogle Scholar